Overview
Valley Forge Pharma is a contract development and manufacturing organization (CDMO) that specializes in peptide therapeutics. It provides integrated services from initial development through commercial supply, focusing on peptide API sourcing, supply chain management, and chemistry, manufacturing, and controls (CMC) development. The core offering is cGMP peptide API manufacturing, using multiple synthesis methods—solid-phase peptide synthesis (SPPS), liquid-phase peptide synthesis (LPPS), ligation chemistry, and fragment condensation—to produce gram- to multi-kilogram-scale batches in Class 100K and Class 10K clean rooms. The company supports various protecting strategies (Boc, Fmoc, Cbz) and ensures quality through a standard analytical package, including mass spectrometry and RP-HPLC purity assessments. Valley Forge Pharma aims to deliver high-quality peptide products at competitive prices to support pharmaceutical research, discovery, and clinical innovation.
Work here?Claim your company
Simplify's Take
What believers are saying
- Website and LinkedIn updated in 2026, showing active operations and market presence.
- Hiring business development in June and August 2026 targets cross-border order growth.
- New wholesale distribution and NABP accreditation work expands revenue beyond manufacturing.
What critics are saying
- No public revenue, funding, or customer names surfaced by September 2026.
- 2026 hiring for DR, shipping, and wholesale distribution signals compliance and execution strain.
- Biopeptek contact details in job posts suggest brand confusion and integration risk.
What makes Valley Forge Pharma unique
- Specializes in cGMP peptide APIs across SPPS, LPPS, ligation, and fragment condensation.
- Runs development through commercial supply from Malvern, Pennsylvania, with custom peptide manufacturing focus.
- LinkedIn cites 40 years combined team experience and state-of-the-art peptide facility.
Help us improve and share your feedback! Did you find this helpful?